Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Loch

Showing results (91-100 of 98) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 98 results.
ACS Medicinal Chemistry Letters|October 24, 2017
Discovery of VU6005649, a CNS Penetrant mGlu<sub>7/8</sub> Receptor PAM Derived from a Series of Pyrazolo[1,5-<i>a</i>]pyrimidinesMasahito Abe, Mabel Seto, Rocco G Gogliotti, et al.
ACS Medicinal Chemistry Letters|December 21, 2017
VU6010608, a Novel mGlu<sub>7</sub> NAM from a Series of <i>N</i>-(2-(1<i>H</i>-1,2,4-Triazol-1-yl)-5-(trifluoromethoxy)phenyl)benzamidesCarson W Reed, Kevin M McGowan, Paul K Spearing, et al.
Antimicrobial Agents and Chemotherapy|December 21, 2011
Pyrrolamide DNA gyrase inhibitors: fragment-based nuclear magnetic resonance screening to identify antibacterial agentsAnn E Eakin, Oluyinka Green, Neil Hales, et al.
ACS Chemical Biology|August 23, 2012
In vivo validation of thymidylate kinase (TMK) with a rationally designed, selective antibacterial compoundThomas A Keating, Joseph V Newman, Nelson B Olivier, et al.
ACS Medicinal Chemistry Letters|March 21, 2019
Discovery of VU2957 (Valiglurax): An mGlu<sub>4</sub> Positive Allosteric Modulator Evaluated as a Preclinical Candidate for the Treatment of Parkinson's DiseaseJoseph D Panarese, Darren W Engers, Yong-Jin Wu, et al.
Journal of Medicinal Chemistry|October 10, 2012
Discovery of selective and potent inhibitors of gram-positive bacterial thymidylate kinase (TMK)Gabriel Martínez-Botella, John N Breen, James E S Duffy, et al.
Der Urologe. Ausg. A|September 27, 2003
[Gemcitabine/cisplatin vs. MVAC. 5 year survival outcome of the phase III study of chemotherapy of advanced urothelial carcinoma in Germany]J Lehmann, M Retz, G Steiner, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 4, 2016
[Not Available]Thomas G Wendt, G Gademann, C Pambor, et al.
Pageof 10

Showing results (91-100 of 98) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 98 results.
ACS Medicinal Chemistry Letters|October 24, 2017
Discovery of VU6005649, a CNS Penetrant mGlu<sub>7/8</sub> Receptor PAM Derived from a Series of Pyrazolo[1,5-<i>a</i>]pyrimidinesMasahito Abe, Mabel Seto, Rocco G Gogliotti, et al.
ACS Medicinal Chemistry Letters|December 21, 2017
VU6010608, a Novel mGlu<sub>7</sub> NAM from a Series of <i>N</i>-(2-(1<i>H</i>-1,2,4-Triazol-1-yl)-5-(trifluoromethoxy)phenyl)benzamidesCarson W Reed, Kevin M McGowan, Paul K Spearing, et al.
Antimicrobial Agents and Chemotherapy|December 21, 2011
Pyrrolamide DNA gyrase inhibitors: fragment-based nuclear magnetic resonance screening to identify antibacterial agentsAnn E Eakin, Oluyinka Green, Neil Hales, et al.
ACS Chemical Biology|August 23, 2012
In vivo validation of thymidylate kinase (TMK) with a rationally designed, selective antibacterial compoundThomas A Keating, Joseph V Newman, Nelson B Olivier, et al.
ACS Medicinal Chemistry Letters|March 21, 2019
Discovery of VU2957 (Valiglurax): An mGlu<sub>4</sub> Positive Allosteric Modulator Evaluated as a Preclinical Candidate for the Treatment of Parkinson's DiseaseJoseph D Panarese, Darren W Engers, Yong-Jin Wu, et al.
Journal of Medicinal Chemistry|October 10, 2012
Discovery of selective and potent inhibitors of gram-positive bacterial thymidylate kinase (TMK)Gabriel Martínez-Botella, John N Breen, James E S Duffy, et al.
Der Urologe. Ausg. A|September 27, 2003
[Gemcitabine/cisplatin vs. MVAC. 5 year survival outcome of the phase III study of chemotherapy of advanced urothelial carcinoma in Germany]J Lehmann, M Retz, G Steiner, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 4, 2016
[Not Available]Thomas G Wendt, G Gademann, C Pambor, et al.
Pageof 10